| Myocardial Perfusion Imaging Hall C |
| 1558. Assessment of First-Pass Stress and Rest Myocardial Perfusion Imaging Using Interleaved Notched Saturation: Comparison with Cardiac Catheterization, S.D. Wolff, C.R. Comeau, G.S. Slavin, T.K.F. Foo and R.A. Hershman, Integrated Cardiovascular Therapeutics, Woodbury, NY, USA and GE Medical Systems, Milwaukee, WI, USA. |
| 1559. High Resolution T2-Weighted First-Pass Myocardial Perfusion Imaging Using Outer-Volume Suppression and the Intravascular Contrast Agent NC100150 Injection, T. Bjerner, L.O. Johansson, A. Bjornerud, G. Wikstrom, H. Ahlström and A. Hemmingsson, Nycomed Imaging A/S, Oslo, Norway and Uppsala University Hospitals, Uppsala, Sweden. |
| 1560. Qualitative Magnetic Resonance Perfusion Imaging in Patients with Coronary Artery Disease, G.R. Cherryman, P.R. Sensky, A. Jivan, C. Reek and N.J. Samani, University of Leicester, Glenfield General Hospital NHS Trust, Leicester, UK. |
| 1561. Quantification of Regional Myocardial Blood Flow in Patients with Coronary Artery Disease by Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), T. Ibrahim, S. Nekolla, K. Schreiber, K. Odaka, S. Volz, M. Güthlin, W. Delius and M. Schwaiger, Technische Universität, München, Germany and Krankenhaus München, Bogenhausen, Germany. |
| 1562. Compensation for Coil Sensitivity Inhomogeneities in Cardiac Perfusion Imaging, P. Storey, M. Zhang, W. Li, D. Bloomgarden, L. Li, R. Edelman and P. Prasad, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. |
| 1563. Imaging Myocardial Ischemia with AngioMARK in the Pig, C.H. Lorenz, M. Taniuchi, J.S. Allen, M. McLean, J.M. Chia, S. Flacke, R.M. Setser, K. Lahti, T. Chan and R. Weisskoff, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO, USA and EPIX Medical, Inc., Cambridge, MA, USA. |
| 1564. How Good is Qualitative Analysis of 1st Pass Gd-DTPA Multislice Myocardial Perfusion Imaging for Clinical Evaluation? D.C. Bloomgarden, P. Storey, W. Li, M. Zhang, L. Li, P. Prasad and R. Edelman, Beth Israel Deaconess Medical Center, Boston, MA, USA. |
| 1565. Clinical Application of Myocardial Perfusion Post PTCA with SE-EPI, F.B. Gao, Y.G. Gao, B.S. Qiu, Y. Liang, Y.Q. Cai and X.Y. Ma, PLA General Hospital and GE Medical Systems China, Beijing, China. |
| 1566. Myocardial Perfusion Mapping With an Intravascular MR Contrast Agent: Performances of Deconvolution Methods at Various Flows, B. Neyran, M. Janier, C. Casali, D. Revel and E. Canet, Hôpital Cardiologique and INSA, Lyon, France. |
| 1567. Blood-Oxygenation-Level-Dependent (BOLD) MRI in Patients with Symptoms of Coronary Artery Disease, M.G. Friedrich, T. Niendorf, J. Schulz-Menger, O. Strohm and R. Dietz, Franz-Volhard-Klinik, University of Berlin, Berlin, Germany and GE Medical Systems, Leipzig, Germany. |
| 1568. Quantitative Assessment of Myocardial Perfusion by First-Pass Dynamic MRI of Intravascular Contrast Agent: Effect of Dose and Hemodynamic State, W.G. Schreiber, G. Horstick, M. Schmitt, S. Petersen, T. Balzer, K-F. Kreitner, T. Voigtländer, J. Meyer and M. Thelen, Johannes Guttenberg-University, Mainz, Germany and Schering AG, Berlin, Germany. |
| 1569. Quantitative Evaluation of Contrast Enhancement in the Normal Myocardium Using a Fast Myocardial Perfusion Sequence with Echo-Planar Readouts, H. Kubo, H. Sakuma, N. Kawada, A. Nozaki, H. Kabasawa, K. Nagasawa and K. Takeda, Mie University School of Medicine, Mie, Japan and GE Yokogawa Medical Systems, Tokyo, Japan. |